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Summary.-The data from a dilution assay can be used not only to form an estimate
of the TD50 (or log TD50), but also to throw light on the transplantation kinetics of
tumours. Transplantation "by single cells" is the simplest sort of kinetics, and
some tumours, of which we have given two examples, will transplant by single cells.
Other tumours consistently transplant with anomalous kinetics-i.e. non-single-
cell. A sensitive statistical test for single-cell behaviour has been developed, and
we give three examples of tumours that clearly fail the test. The mechanism by
which these anomalous tumours depart from single-cell behaviour is unknown, but
we suggest an approximate statistical analysis for their assay.
THE technique of dilution assay was
first applied to malignant cells (of a mouse
leukaemia) by Hewitt and Wilson (1959).
Since then the technique has been applied
to a wide variety oftumours by Berry and
Andrews (1961), Reinhold (1967) and by
many others. In these studies the assays
have usually merely provided data from
which the authors deduce survival curves,
anoxic fractions, or other information of
exclusively radiobiological interest. How-
ever in the wider context of general
tumour biology, dilution assays can throw
light on the transplantation kinetics of
tumour cells, and this may be as important
for the understanding of the process of
metastasis as, for example, the " cell-loss
factor " has been for the understanding of
the process of tumour growth.
In a dilution assay, a cell-suspension
is prepared and the density of morpho-
logically intact tumour cells is estimated
by counting. Inocula of different sizes
are prepared by serial dilution and injected
into recipient animals. A single animal
can provide several subcutaneous sites for
injection, or one intraperitoneal site.
After a sufficient period ofobservation the
number of takes and failures to take for
each site of inoculum is scored. The
characteristic feature of this type of assay
is that each site (or animal) shows only
whether its inoculum produced a tumour
or not; the number of cells contributing to
a take is not shown. The name " dilution
assay" is therefore inept (serial dilutions
are an essential part of most biological
assays), but this is the term generally used
and its limits are understood.
The results of a dilution assay can be
used to calculate a TD50 (the number of
tumour cells required to produce 5000
takes), and TD50's are commonly inter-
preted on the theory that:
(1) Some of the tumour cells are
clonogenic.
(2) An inoculum produces a take if,
and only if, it contains at least one
clonogenic cell.
(3) Any non-clonogens in the inoculum
have no influence on the outcome (take or
no take).
A tumour that obeys these three
assumptions will be described here as
transplanting " by single cells ". This is,
of course, the simplest possible sort of
transplantation kinetics, and leads to a
simple interpretation of the TD50 as that
inoculum size which contains 0-693 clono-
gens on average.E. H. PORTER, H. B. HEWITT AND EILEEN R. BLAKE
We show in this paper how to test
assay results for consistency with single-
cell transplantation, and give examples of
mouse tumours which do transplant by
single cells and of some that do not. Our
examples come from assays of 5 tumours
of spontaneous origin in one or other of
the inbred mouse strains CBA/Ht and
WHT/Ht.
SINGLE-CELL TRANSPLANTATION KINETICS
Finney (1964) gives a lucid and con-
vincing treatment of the single-cell case.
If an inoculum contains, on average, m
clonogenic cells, then the chance (p) of
failure to take will be:
p ~e-m(1)
where e is the base of natural logarithms.
For transplantation by single cells, the
average number of clonogens (m) will be
proportional to the inoculum size (z):
(2) m =k.z
and this can be rewritten as
log m = log k + log z
In the present context, z will be a number
of morphologically intact tumour cells, so
that k will be a clonogenic fraction.
Finney shows that it is best to work in
terms of the logarithm of inoculum size
(as in equation 3), and hence to derive an
estimate ofthe logarithm ofthe clonogenic
fraction: the logarithm has a nearly
normal error-distribution, whereas a direct
estimate of k would have a highly non-
normal one.
Finney's method is an iterative one for
arriving at the maximum likelihood esti-
mate of log k, together with its standard
log. inoculum size
FIG. 1.-Pooled data from 10 control assays of CBA 'NT', with the fitted single-cell curve,
illustrating good agreement. The assays were performed over a period of 13 months and 25
serial passages of the tumour. Seven points, all at 0% takes, lie beyond the left-hand side of the
figure, so the statistical analysis (see text) is based on 32 points in all. Points represent x/16,
with a few x/20 and x/32.
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error and a chi-square value for deviations
from the single-cell curve. In the single-
cell case the TD50 is that inoculum size
which contains 0-693 (loge2) clonogens, so
that it is very straightforward to pass
from an estimate of the log clonogenic
fraction to an estimate of the log TD50.
It is almost as straightforward to pass
from natural logarithms to common (base
ten) logarithms: such conversions from
the unfamiliar to the familiar are a great
help to the non-mathematician. Here the
conversions will be assumed: all results
will be quoted in terms oflog TD50's, and
all logarithms will be to base ten.
Fig. 1 shows the single-cell curve
fitted by Finney's method to pooled data
from 10 assays of one transplantable
tumour, the CBA ' NT ', which is a poorly
differentiated carcinoma. The calculation
gives a log TD50 of 3-84 with s.e. 0-038,
and a chi-square for deviations from the
single-cell curve of 25 7 with 31 degrees of
freedom (d.f.). Fig. 1 gives a visual
impression of a good fit between curve and
data, and the low value of chi-square
confirms that the fit is good; but if the
numbers ofsites and the numbers oftakes
in all the experiments had all been ten
times larger the figure would have looked
the same, and the calculation would have
shown, correctly, a highly significant
value of chi-square.
The statistical analysis illustrated by
Fig. 1 shows not only that the tumour
' NT ' transplants by single cells, but also
that its log TD50 has remained effectively
constant over 13 months and 25 serial
passages. For if the log TD50 had not
remained constant, the chi-square for the
pooled data would have been significantly
inflated over the sum of the chi-squares
for the assays analysed separately. Here
the difference (pooled-separate) is a chi-
square of 13-3, which with 9 d.f. is not
significant.
Fig. 2 shows a similar plot of the data
from six assays of the WHT Sq. Ca. 'D',
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FIG. 2.-Pooled data from 6 assays of WHT Sq. Ca. 'D', with the fitted single-cell curve,
illustrating good agreement. There are 23 points, each representing x/24 or x/16.
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a keratinizing squamous carcinoma which
has been fully described by Hewitt, Chan
and Blake (1967). The calculations give
a log TD50 of 1-29 with s.e. 0044, and a
chi-square of 16 8 with 22 degrees of
freedom, which shows good agreement with
single-cell kinetics.
Two other assays of Sq. Ca. ' D ' have
been omitted from Fig. 2: they also
agreed well with single-cell kinetics (chi-
square 06 with 6 d.f.), but they pointed
to a log TD50 of 0-88, significantly below
1-29. We believe that the apparent
difference in log TD50's stems from the
use of different criteria for morphologi-
cally intact tumour cells at the counting
stage. It is less easy to maintain stable
criteria with a more differentiated tumour,
and the series of assays extended over 4
years. That all 8 assays show single-cell
behaviour supports this interpretation:
counting criteria cannot influence trans-
plantation kinetics.
A comparison between Fig. 1 and Fig.
2 illustrates one advantage ofdealing with
logarithms of the inoculum size. The
single-cell curve in the two figures is the
same in shape and slope; only its position
is affected by the difference between the
log TD50's. The shape of the single-cell
curve is not symmetrical: its upper half
(above the 50%O point) is steeper than its
lower half. The data both of Fig. 1 and
of Fig. 2 suggest a curve that is steeper in
its upper half, but a clear delineation of
such asymmetry as this would require an
impracticably large amount of experi-
mentation.
The slope of the single-cell curve at
any point does not depend on the log
log. inoculum size
FIG. 3. Data from 5 assays of WVHT Bone Sa. I, and 3 of WHT Bone Sa. II, illustrating poor
agreement with a single-cell curve. Each point is plotted relative to the log TD50 of its own
assay, except that the 2 control assays of Bone Sa. I have been pooled. Two points at 0°0
takes lie beyond the left-hand side of the figure, and two at 100% takes beyond its right-hand side.
The analysis is thus based on 40 points in all, and seven log TD50's have been computed, leaving
33 d.f. for the chi-square measuring (lepartures from the single-cell curve. Points represent
x/16, with a few x/12 and x/8.
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TD50, but only on the take percentage at
that point. It is therefore possible for a
tumour to transplant according to an
assay curve that is consistently and
detectably shallower (or steeper) than the
single-cell curve. Such a difference in
average slope can be detected with a
reasonable amount of experimentation.
ANOMALOUS TRANSPLANTATION KINETICS
Fig. 3 shows a single-cell curve, to-
gether with the data from 5 assays of
WHT Bone Sa. I, and 3 assays of WHT
Bone Sa. II. These are fibrosarcomata,
which arose separately and spontaneously
in bone; neither transplants by single
cells, and their transplantation behaviour
is so similar that they can be considered
together. Their log TD50's, however, are
quite different, so the data from each
assay has been plotted in Fig. 3 relative
to its own log TD50, thus combining the
witness of all 8 assays against the single-
cell curve.
The single-cell curve of Fig. 3 is clearly
too steep to represent the points; and the
chi-square for deviations from the single-
cell curve is 2476 with 33 degrees of
freedom, well beyond the 011% level.
The points seem to be scattered round a
shallower curve, and this suggests that the
value of chi-square should be divisible into
two parts: one with 32 d.f. measuring the
scatter about a shallower curve, and
another with 1 d.f. measuring the signifi-
cance of the difference in slope between
the shallower curve and the single-cell
curve.
Such an analysis of chi-square requires
that Finney's work should be extended to
make the single-cell curve one member of
a family of curves with different slopes.
Such an extension can be made in an
indefinite nuimber of ways and the one of
choice would be the one appropriate to
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FIG. 4. Data as in Fig. 3; curve has the same shape as the single-cell curve but half its slope
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the biological situation. But the biological
situation is not understood, the correct
extension cannot be found, and a simple
and convenient extension is the next
best thing.
We therefore suggest extending
Finney's argument to allow for a variable
slope of the curve, but keeping the single-
cell shape. Algebraically this amounts to
replacing equation 3 by:
log m log k +s.log z (4)
where s measures the slope. This gives a
family of curves, and the member with
8 - 1 0 is of course the single-cell curve.
Within this family the data of Fig. 3 fit
best to a curve with a slope of 0 5, shown
in Fig. 4. The chi-square for deviations
from this curve is 30'9 with 32 d.f., which
allows the analysis of chi-square to be
completed by subtraction:
source of variation
deviations from curve
withs 5= O5
difference in slope
deviations from
single-cell curve
chi-square d.f.
30 9 32
216- 7 1
247- 6 33
This analysis of the data of Fig. 3
shows that they violently reject the single-
cell curve. We may be sure that the two
tumours (Bone I and Bone II) do not
transplant by single cells. But their true
transplantation kinetics remain obscure,
for the curve of Fig. 4 has no biological
meaning, even though the scatter ofpoints
about it is no more than should be
expected by chance. Taken literally,
equation 4 with s 0 5 means that the
number of clonogens in an inoculum is
proportional to the square root of inocu-
lum size, and as a theory of transplanta-
tion behaviour this is incredible. But the
curve of Fig. 4 must provide a good
approximation to the true curve, its slope
is approximately correct, and its shape
may even be asymmetric in the right way,
for the points of Fig. 4 suggest a curve
with its upper half steeper than the
lower half.
The same analysis of chi-square can
be applied to the data ofFig. 1, to produce
a chi-square for " difference in slope " of
0 1, which shows excellent agreement with
single-cell kinetics. The data of Fig. 2
yield a chi-square for " difference in
slope" of 3-6, which with 1 d.f. is not
significant. These low values of chi-
square are good evidence for single-cell
transplantation kinetics, because the
analysis of chi-square gives a sensitive
test of the slope of the curve.
The CBA Sa. 'F', another fibro-
sarcoma, shows an intermediate type of
transplantation kinetics. The combined
data from 4 assays give this analysis of
chi-square:
source of variations
deviations from curve
with s = 0 7
difference in slope
deviations from
single-cell curve
chi-square
25-8
19-0
44-8
d.f.
25
1
26
The single-cell curve is rejected with a
chi-square well beyond the 001% level.
We may be sure that Sa. ' F ' does not
transplant by single cells, and that
equation 4 with s - 0 7 gives a good
approximation to its transplantation kin-
etics. But this is only an approximation;
it is incredible that the number of clono-
gens should be proportional to the 0-7th
power of inoculum size.
If a tumour does not transplant by
single cells, its assays should not be
analysed by Finney's method. Such an
inappropriate analysis will only slightly
bias the estimate of the log TD50, but it
will give badly misleading standard errors.
Where the single-cell curve is too steep,
Finney's method will give unrealistically
small standard errors; we have never
found a tumour to transplant by a curve
steeper than the single-cell one. The
extension suggested here will give approxi-
mately correct standard errors once the
slope (s) has been estimated, and we
recommend it as an approximation.
In practice the slope is not well
estimated by any one assay, and it will be
necessary to combine the analyses of
60THE TRANSPLANTATION KINETICS OF TUMOUR CELLS
several assays in order to estimate the
slope with enough precision to be useful.
For example, the individual assays of
Fig. 3 and 4 point to values of s ranging
from 0 4 to 0 7, but they are all consistent
with the value s 0-5. In fact, curves
with s= 0 45 or 8 s 0 55 do not fit the
data significantly less well than the curve
with 8 - 05 does, so that the relative
uncertainty of an estimated slope will
always be quite large.
DISCUSSION
If anomalous transplantation kinetics
gave a slope steeper than the single-cell
slope, interpretation would be easy. For if
two cooperating cells are required for a
take the resulting (2-cell) curve is steeper
than the single-cell curve, and more nearly
symmetrical. The 3-cell curve is steeper
still and still more nearly symmetrical,
and so on. But our anomalous tumours
give anomalously low slopes.
In theory, anomalously low slopes can
arise from unrecognized variability in the
recipient animals. For example, if the
log TD50 is different in males and females,
if this difference amounts to 0 3 logs, and
ifthe assay groups contain equal numbers
of males and females, then the theoretical
assay curve can be calculated, and it turns
out to have a slope of0 95. To produce an
apparent slope of 0 5 requires a difference
of 14 logs (a factor 25 in the TD50's
themselves), and this would lead fre-
quently to the finding that the same size
of inoculum produces four takes in one
mouse and no takes in another. This
finding is rare in our assays. A dominant
gene possessed by half the assay mice
could produce the same results (a lowered
slope and frequent combinations of 4/4
and 0/4 tumours).
In a similar way, major technical
errors will give an assay with a lowered
slope, by effectively making it estimate
several log TD50's simultaneously. But
here the sameproceduresinthe samehands
consistently give single-cell kinetics with
two tumours and anomalous kinetics with
three others. Consistent results cannot
be explained by unpredictable major
errors.
Random errors of counting and dilu-
tion will of course add to the variance of
estimate of the log TD50 derived from an
assay. The figures given here neglect this
source of variation, but an estimate can
be formed that it at worst adds 10% to
the variance. The effect on the assay
slope is negligibly small.
It is possible to alter the log TD50's of
these tumours by assaying them in
recipients given whole-body irradiation,
and by adding lethally irradiated cells to
each inoculum. Such treatments can
change the log TD50 by up to 3 logs (a
factor 1000), and their effects will be
discussed in another paper; it is here
relevant that they do not detectably alter
the transplantation kinetics, whether
these are single-cell or anomalous.
Each tumour thus seems to have its
own characteristic and consistent trans-
plantation kinetics, and this may well
apply generally. The leukaemia studied
by Hewitt and Wilson (1959) and the
ascites tumour studied by Berry and
Andrews (1961) both transplant by single
cells; and the rat rhabdomyosarcoma of
Reinhold (1967) transplants with an
anomalously low slope.
Of the 5 tumours discussed here, the
2 carcinomata transplant by single cells
and the 3 sarcomata transplant anoma-
lously. The association is probably mis-
leading, for a small number of assays of a
sixth tumour (the WHT Sq. Ca. ' G ')
point to a lower slope than the single-cell
one, but give insufficient data for more
than this negative statement.
Immunological factors can be invoked
to account for anything from rejection of
a tumour to enhancement of its growth.
It is therefore tempting to explain
anomalous transplantation kinetics as an
immunological manifestation. There are,
however, reasons against accepting such
an explanation. These tumours are all
spontaneous, and arose in mouse strains
of low cancer incidence. Viruses and
61E. H. PORTER, H. B. HEWITT AND EILEEN R. BLAKE
chemical carcinogens, which can produce
definitely antigenic tumours, played no
part here. The assays were done in mice
of the same strain, and indeed the same
colony as that in which the tumour
arose and had always been transplanted;
in these circumstances we have never
succeeded in altering a TD50 by " im-
munizing " the recipients, and we have
never seen spontaneous remission.
The transplantation kinetics of the
anomalous tumours thus remain a
mystery. It does not seem to be possible
to account convincingly for the findings on
the basis of variability in the recipient
mice, technical error, or immunological
incompatibility between the tumours and
their syngeneic hosts. The assays can be
analysed by a method which implies that
the number of clonogens in an inoculum
varies as a fractional power of its size: the
implication is incredible, but the approxi-
mation is useful.
We are grateful to Miss Angela Walder
for the breeding and care of all the mice
used in the experiments, and to the Cancer
Research Campaign for their full support
of the Gray Laboratory, in which all the
experiments were performed.
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